{"filing":{"accession_number":"0001171843-26-005868","cik":"0001628808","ticker":"PROF","company_name":"Profound Medical Corp.","form":"8-K","filing_date":"2026-09-03","report_date":"2026-09-01","primary_document":"f8k_090326.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1628808/000117184326005868/f8k_090326.htm"},"events":[{"id":31465,"run_id":28871,"accession_number":"0001171843-26-005868","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"Richard R. Fabian was appointed President of Profound Medical effective September 1, 2026, succeeding Mathieu Burtnyk who transitioned to Chief Technology Officer. Fabian brings 29+ years of healthcare industry experience, including prior roles as CEO of FUJIFILM Sonosite and executive positions at Philips Healthcare and STERIS, with a compensation package of $550,000 base salary, up to 100% bonus, 200,000 RSUs, and 475,000 options.","company_name":"Profound Medical Corp.","ticker":"PROF","filing_date":"2026-09-03","form":"8-K","submitted_at":null,"items":[{"id":34353,"accession_number":"0001171843-26-005868","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Richard R. Fabian was appointed President of Profound Medical effective September 1, 2026, succeeding Mathieu Burtnyk who transitioned to Chief Technology Officer. The filing discloses Fabian's extensive executive background (former CEO of FUJIFILM Sonosite, prior roles at Philips Healthcare and STERIS), his compensation package ($550,000 base salary, up to 100% bonus, 200,000 RSUs, 475,000 options), and relocation benefits. This is a material executive appointment to a key operational leadership position at a commercial-stage medical device company.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-03T11:08:53.368303+00:00","company_name":"","ticker":null,"filing_date":""},{"id":34354,"accession_number":"0001171843-26-005868","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Richard Fabian as President of Profound Medical Corp., effective immediately, as announced in a press release on September 1, 2026. While the Item 7.01 section references Item 5.02 (the standard Item for executive changes), the principal disclosed action is a person taking a key executive role. The appointment of a President with significant healthcare industry experience (29+ years, former CEO of FUJIFILM Sonosite) to lead operations at a commercial-stage medical device company is material to investors assessing management quality and execution capability.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-03T11:08:53.368303+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":34353,"accession_number":"0001171843-26-005868","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Richard R. Fabian was appointed President of Profound Medical effective September 1, 2026, succeeding Mathieu Burtnyk who transitioned to Chief Technology Officer. The filing discloses Fabian's extensive executive background (former CEO of FUJIFILM Sonosite, prior roles at Philips Healthcare and STERIS), his compensation package ($550,000 base salary, up to 100% bonus, 200,000 RSUs, 475,000 options), and relocation benefits. This is a material executive appointment to a key operational leadership position at a commercial-stage medical device company.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-03T11:08:53.368303+00:00","company_name":"Profound Medical Corp.","ticker":"PROF","filing_date":"2026-09-03"},{"id":34354,"accession_number":"0001171843-26-005868","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Richard Fabian as President of Profound Medical Corp., effective immediately, as announced in a press release on September 1, 2026. While the Item 7.01 section references Item 5.02 (the standard Item for executive changes), the principal disclosed action is a person taking a key executive role. The appointment of a President with significant healthcare industry experience (29+ years, former CEO of FUJIFILM Sonosite) to lead operations at a commercial-stage medical device company is material to investors assessing management quality and execution capability.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-03T11:08:53.368303+00:00","company_name":"Profound Medical Corp.","ticker":"PROF","filing_date":"2026-09-03"}]}